Your browser doesn't support javascript.
loading
Acetyl-CoA Synthetase 2: A Critical Linkage in Obesity-Induced Tumorigenesis in Myeloma.
Li, Zongwei; Liu, Huan; He, Jin; Wang, Zhiqiang; Yin, Zheng; You, Gichun; Wang, Zhiming; Davis, Richard E; Lin, Pei; Bergsagel, P Leif; Manasanch, Elisabet E; Wong, Stephen T C; Esnaola, Nestor F; Chang, Jenny C; Orlowski, Robert Z; Yi, Qing; Yang, Jing.
Afiliación
  • Li Z; Houston Methodist Cancer Center, Houston Methodist Research Institute, Houston Methodist Hospital, Houston, TX 77030, USA; Departments of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Liu H; Houston Methodist Cancer Center, Houston Methodist Research Institute, Houston Methodist Hospital, Houston, TX 77030, USA; Departments of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • He J; Houston Methodist Cancer Center, Houston Methodist Research Institute, Houston Methodist Hospital, Houston, TX 77030, USA; Departments of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Wang Z; Departments of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Yin Z; Center for Bioengineering and Informatics, Houston Methodist Research Institute, Houston Methodist Hospital, Houston, TX 77030, USA.
  • You G; Houston Methodist Cancer Center, Houston Methodist Research Institute, Houston Methodist Hospital, Houston, TX 77030, USA; Departments of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Wang Z; Houston Methodist Cancer Center, Houston Methodist Research Institute, Houston Methodist Hospital, Houston, TX 77030, USA; Departments of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Davis RE; Departments of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Lin P; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Bergsagel PL; Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ 85259, USA.
  • Manasanch EE; Departments of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Wong STC; Center for Bioengineering and Informatics, Houston Methodist Research Institute, Houston Methodist Hospital, Houston, TX 77030, USA.
  • Esnaola NF; Houston Methodist Cancer Center, Houston Methodist Research Institute, Houston Methodist Hospital, Houston, TX 77030, USA.
  • Chang JC; Houston Methodist Cancer Center, Houston Methodist Research Institute, Houston Methodist Hospital, Houston, TX 77030, USA.
  • Orlowski RZ; Departments of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Yi Q; Houston Methodist Cancer Center, Houston Methodist Research Institute, Houston Methodist Hospital, Houston, TX 77030, USA. Electronic address: qyi@houstonmethodist.org.
  • Yang J; Houston Methodist Cancer Center, Houston Methodist Research Institute, Houston Methodist Hospital, Houston, TX 77030, USA; Departments of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: jyang2@houstonmethodist.org.
Cell Metab ; 33(1): 78-93.e7, 2021 01 05.
Article en En | MEDLINE | ID: mdl-33406405
ABSTRACT
Obesity is often linked to malignancies including multiple myeloma, and the underlying mechanisms remain elusive. Here we showed that acetyl-CoA synthetase 2 (ACSS2) may be an important linker in obesity-related myeloma. ACSS2 is overexpressed in myeloma cells derived from obese patients and contributes to myeloma progression. We identified adipocyte-secreted angiotensin II as a direct cause of adiposity in increased ACSS2 expression. ACSS2 interacts with oncoprotein interferon regulatory factor 4 (IRF4), and enhances IRF4 stability and IRF4-mediated gene transcription through activation of acetylation. The importance of ACSS2 overexpression in myeloma is confirmed by the finding that an inhibitor of ACSS2 reduces myeloma growth both in vitro and in a diet-induced obese mouse model. Our findings demonstrate a key impact for obesity-induced ACSS2 on the progression of myeloma. Given the central role of ACSS2 in many tumors, this mechanism could be important to other obesity-related malignancies.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Acetato CoA Ligasa / Mieloma Múltiple / Obesidad Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Cell Metab Asunto de la revista: METABOLISMO Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Acetato CoA Ligasa / Mieloma Múltiple / Obesidad Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Cell Metab Asunto de la revista: METABOLISMO Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
...